Biorchestra

Developer of RNA based medicines for treating neurodegnerative disease

placeYuseong District, Hoseo, South Korea calendar_todayFounded 2016 groups85 employees language biorchestra.com

Registered entities

Innovation

46 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 827 times.

YearFilings
20182
20192
20208
202111
202220
202320
202423
20258
20261

Investor mix

16 investors on record; lead investors include Daily Partners, IMM Investment, SBI Mutual Fund, Smile Gate Investment.

Investor typeCountShare
Venture capital638%
Private equity425%
Accelerator & incubator16%
Other / undisclosed531%
Coming soon